These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28239793)

  • 1. NPY
    Masliuko PM; Anikina TA; Zverev AA; Krylova AV; Moiseev KY; Zefirov TL
    Bull Exp Biol Med; 2017 Feb; 162(4):418-420. PubMed ID: 28239793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive Intestinal Peptide Changes the Frequency and Force of Myocardial Contraction in Rats.
    Zverev AА; Leonov NV; Аnikina ТА; Zefirov ТL
    Bull Exp Biol Med; 2020 Oct; 169(6):787-790. PubMed ID: 33098516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoceptors in Dopaminergic Regulation of Rat Myocardial Contractility in Rats During Ontogeny.
    Bilalova GA; Sitdikov FG; Dikopol'skaya NB; Shaikhelislamova MV; Zefirov TL
    Bull Exp Biol Med; 2017 Apr; 162(6):769-772. PubMed ID: 28429217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of neuropeptide Y in myocardial contractility of rats during early postnatal ontogeny.
    Zverev AA; Anikina TA; Maslyukov PM; Zefirov TL
    Bull Exp Biol Med; 2014 Aug; 157(4):421-3. PubMed ID: 25110075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Blockade of α
    Zefirov TL; Khisamieva LI; Ziyatdinova NI; Zefirov AL
    Bull Exp Biol Med; 2016 Dec; 162(2):177-179. PubMed ID: 27909967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.
    Heredia Mdel P; Delgado C; Pereira L; Perrier R; Richard S; Vassort G; Bénitah JP; Gómez AM
    J Mol Cell Cardiol; 2005 Jan; 38(1):205-12. PubMed ID: 15623437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.
    Serone AP; Angus JA
    Br J Pharmacol; 1999 May; 127(2):383-90. PubMed ID: 10385237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
    Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria.
    Balasubramaniam A; Grupp I; Matlib MA; Benza R; Jackson RL; Fischer JE; Grupp G
    Regul Pept; 1988 Jun; 21(3-4):289-99. PubMed ID: 3413295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic effect of dopamine on rat heart during postnatal ontogeny.
    Bilalova GA; Kazanchikova LM; Zefirov TL; Sitdikov FG
    Bull Exp Biol Med; 2013 Dec; 156(2):173-6. PubMed ID: 24319741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Kuo MH; Kuo DY
    Arch Toxicol; 2013 Mar; 87(3):469-79. PubMed ID: 23052195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes.
    Nicholl SM; Bell D; Spiers Jp; McDermott BJ
    Eur J Pharmacol; 2002 Apr; 441(1-2):23-34. PubMed ID: 12007917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y mediates cardiac hypertrophy through microRNA-216b/FoxO4 signaling pathway.
    Wang J; Hao D; Zeng L; Zhang Q; Huang W
    Int J Med Sci; 2021; 18(1):18-28. PubMed ID: 33390770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.